Page 173 - medicina-integrativa_compress
P. 173
166 PARTE II, SECCIÓN 2 NEUROLOGÍA
7. White CM, Pritchard J, Turner-Stokes L: Exercise for people 30. Horrobin DF: A new concept of lifestyle-related cardiovascular
with peripheral neuropathy. Cochrane Database Syst Rev disease: The importance of interactions between cholesterol,
(4):CD003904, 2004. essential fatty acids, prostaglandin E 1 and thromboxane A 2 . Med
8. Jablon SL, Nalifboff BD, Gilmore SL, Rosenthal MJ: Effects Hypotheses 6:785-800, 1980.
of relaxation training on glucose tolerance and diabetic control 31. Brenner RR: Nutritional and hormonal factors influencing
in type II diabetes. Appl Psychophysiol Biofeedback 22: desaturation of essential fatty acids. Progr Lipid Res 20:41-48, 1982.
155-169, 1997. 32. Boberg M, Vessby B, Selinus I: Effects of dietary supplementation
9. Rosenbaum L: Biofeedback-assisted stress management for with n-6 and n-3 long-chain polyunsaturated fatty acids on serum
insulin-treated diabetes mellitus. Biofeedback Self-Regul 8: lipoproteins and platelet function in hypertriglyceridaemic patients.
519-532, 1983. Acta Med Scand 220:153-160, 1986.
10. Kochman AB, Carnegie DH, Burke TJ: Symptomatic reversal of 33. Takahashi R, Inoue J, Ito H, et al: Evening primrose oil and fish oil
peripheral neuropathy in patients with diabetes. J Am Podiatr Med in non-insulin dependent diabetes. Prostaglandins Leukot Essent
Assoc 92:125-130, 2002. Fatty Acids 49:569-571, 1993.
11. Kalinina OV, Alekseeva NV, Burtsev EM: Infrared laser therapy in 34. Halat KM, Dennehy CE: Botanicals and dietary supplements in
distal diabetic polyneuropathy. Zh Nevrol Psiskhiatr IM S S diabetic peripheral neuropathy. J Am Board Fam Pract 16:47-57, 2003.
Korsakova 98:23-25, 1998. 35. Pisano C, Laccabue D, Zunino F, et al: Paclitaxel and cisplatin-
12. Powell MW, Carnegie DE, Burke TJ: Reversal of diabetic peripheral induced neurotoxicity: A protective role of acetyl-L-carnitine.
neuropathy and new wound incidence: The role of MIRE. Adv Skin Clin Cancer Res 9:5756-5767, 2003.
Wound Care 17:295-300, 2004. 36. Ghirardi O, Vertechy M, Vesci L, et al: Chemotherapy-induced
13. Leonard DR, Farooqi MH, Myers S: Restoration of sensation, allodynia: Neuroprotective effect of acetyl-L-carnitine. In Vivo
reduced pain, and improved balance in subjects with diabetic 19:631-637, 2005.
peripheral neuropathy: A double-blind, randomized, placebo- 37. Maestri A, De Pasquale Ceratti A, Zanna C, et al: A pilot study on
controlled study with monochromatic near infrared treatment. the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced
Diabetes Care 27:168-172, 2004. peripheral neuropathy. Tumori 91:135-138, 2005.
14. Weintraub MI, Wolfe GI, Barohn RA, et al: Static magnetic field 38. Bianchi G, Vitali G, Caraceni A, et al: Symptomatic and
therapy for symptomatic diabetic neuropathy: A randomized, neurophysiological responses of paclitaxel- or cisplatin-induced
double-blind, placebo-controlled trial. Arch Phys Med Rehabil neuropathy to oral acetyl-L-carnitine. Eur J Cancer 41:1746-1750,
84:736-746, 2003. 2005.
15. Weintraub MI: Magnetic biostimulation in painful diabetic 39. Sima A, Calvani M, Mehra M, et al: Acetyl-L-carnitine improves
neuropathy. Am J Pain Manage 9:8-17, 1999. pain, nerve regeneration, and vibratory perception in patients with
16. Tsigos C: Cerebrospinal fluid levels of beta endorphin in painful chronic diabetic neuropathy: An analysis of two randomized
and painless diabetic polyneuropathy. J Diabetes Complications placebo-controlled trials. Diabetes Care 28:89-94, 2005.
9:92-96, 1995. 40. De Grandis D, Minardi C: Acetyl-L-carnitine (levacecarnine) in the
17. Han JS, Ding XZ, Fan SG: Cholecystokinin octapeptide (CCK-8) treatment of diabetic neuropathy. A long-term, randomized, double-
antagonism to electroacupuncture analgesia and a possible role in blind, placebo-controlled study. Drugs R D 3:223-231, 2002.
electroacupuncture tolerance. Pain 27:101-115, 1986. 41. Ametov A, Barinov A, Dyck PJ, et al: The sensory symptoms of
18. Abuaisha BB, Costanzi JB, Boulton AJM: Acupuncture for the diabetic polyneuropathy are improved with alpha-lipoic acid (the
treatment of chronic painful peripheral neuropathy: A long-term SYDNEY Trial). Diabetes Care 26:770-776, 2003.
study. Diabetes Res Clin Pract 39:115-121, 1998. 42. Herman R, Gleiter GH, Niebch G, et al: [liponsaure (Thioctsaure)—
19. Ewins DL, Vileikyte L, Borg-Costanzi JB, et al: Acupuncture: A novel aktueller stand zur enantioselektiven pharmakokinetik bei gesunden
treatment for painful diabetic neuropathy. In Diabetic Neuropathy: und diabetikern.] Diabet Stoffwechsel 5:5-11, 1996.
New Concepts and Insights. Amsterdam: Excerpta Medica, 1995, 43. Merz PG, Rietbrock S, Schordter A, et al: [Orales—
pp 405-408. liponsaurepraparat erweist gute bioverfugbarketi.] Therapie Woche
20. Ionescu-Targoviste C, Phleck-Khhayan A, Danciu V, et al: The 23:1367-1370, 1995.
treatment of peripheral polyneuritis by electroacupuncture. Am J 44. Packer L, Witt E, Tritschler H: Alpha-lipoic acid as a biological
Acupunct 9:92-96, 1981. antioxidant. Free Radic Biol Med 2:227-250, 1995.
21. O’Connor J, Bensky D: Acupuncture: A Comprehensive Text. 45. Peter G, Borbe HO: [Untersuchungen zur absorption und verteilung
Chicago, Shanghai College of Traditional Medicine/Eastland der thioctsaure als grundlage der klinischen wirksamketi bei der
Press, 1981. behandlung der diabetischen polyneuropathie.] Diabet Stoffwechsel
22. Irnich D, Winklmeirer S, Bever A, Peter K: Electric stimulation 5:12-16, 1996.
acupuncture in peripheral neuropathic pain syndromes: Clinical 46. Smith AR, Shenvi SV, Widlansky M, et al: Lipoic acid as a potential
pilot study on analgesic effectiveness. Schmerz 16:114-120, 2002. therapy for chronic disease associated with oxidative stress. Curr
23. Ionescu-Targoviste C, Phleck-Khhayan A, Danciu V, et al: The Med Chem 11:1135-1146, 2004.
treatment of peripheral polyneuritis by electroacupuncture. Am J 47. Nagamatsu M, Nikander KK, Schmeizer J, et al: Lipoic acid
Acupunct 9:92-96, 1981. improves nerve blood flow, reduces oxidative stress, and improves
24. Greenway FL, Frome BM, Engels TM, et al: Temporary relief of distal nerve conduction in experimental diabetic neuropathy.
postherpetic neuralgia pain with topical geranium oil. Am J Med Diabetes Care 18:1160-1167, 1995.
15:586-587, 2003. 48. Ziegler D, Hanefeld M, Ruhnau KJ, et al, and the ALADIN Study
25. Neuragen: Peripheral Neuropathy Effectiveness Survey Results. Group: Treatment of symptomatic diabetic peripheral neuropathy with
Conducted by Origin Biomedicinals in collaboration with the antioxidant alpha-lipoic acid. Diabetologia 38:1425-1433, 1995.
DiabetesinControl.com. www.originbiomed.com. Product 49. Ziegler D, Schatz H, Conrad F, et al: Effect of treatment with the
Information Sheet on Neuragen, December 2004. antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in
26. Halat KM, Dennehy CE: Botanicals and Dietary Supplements NIDDM patients: A 4-month randomized, controlled multicenter
in Diabetic Peripheral Neuropathy. J Am Board Fam Pract 16: trial (DEKAN Study). Diabetes Care 20:369-373, 1997.
47-57, 2003. 50. Reljanovic M, Reichel G, Rett K, et al: treatment of diabetic peripheral
27. Coste TC, Gerbi A, Vague P: Peripheral diabetic neuropathy and neuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A
polysaturated fatty acid supplementation: Natural sources or two-year multicenter randomized double-blind placebo-controlled
biotechnological needs? Cell Mol Biol (Noisy-le-grand) 50:845-853, trial (ALLADIN II). Free Radic Res 31:171-179, 1999.
2004. 51. Ziegler D, Hanefeld M, Ruhnau KJ, et al: Treatment of symptomatic
28. Coste T, Pierlovisi M, Leonardi J, et al: Beneficial effects of gamma diabetic polyneuropathy with the antioxidant alpha-lipoic acid:
linolenic acid supplementation on nerve conduction velocity, Na+, A 7-month multicenter randomized controlled trial (ALLADIN III
K+-ATPase activity, and membrane fatty acid composition in sciatic Study). Diabetes Care 22:1296-1301, 1999.
nerve of diabetic rats. J Nutr Biochem 10:411-420, 1999. 52. Ruhnau KJ, Meissner HP, Finn JR, et al: Effect of a 3-week oral
29. Horrobin DF: The role of essential fatty acids in the development of treatment with the antioxidant thioctic acid (alpha-lipoic acid) in
diabetic neuropathy and other complications of diabetes mellitus. symptomatic diabetic polyneuropathy. Diabet Med 16:1040-1043,
Prostaglandins Leukot Essent Fatty Acids 31:181-197, 1988. 1999.